Sezer Acar1, Salih Gözmen2, Selen Bayraktaroğlu3, Sultan O. Acar2, Neryal Tahta2, Yeşim Aydınok4, Raziye C. Vergin2. 1. Dr. Behçet Uz Child Disease and Pediatric Surgery Training and Research Hospital, Department of Pediatrics, İzmir, Turkey 2. Dr. Behcet Uz Child Disease and Pediatric Surgery Training and Research Hospital, Division of Pediatric Hematology and Oncology, İzmir, Turkey 3. Ege University Faculty of Medicine, Department of Radiology, İzmir, Turkey 4. Ege University Faculty of Medicine, Division of Pediatric Hematology and Oncology, İzmir, Turkey
Abstract
Objective: There are a limited number of studies evaluating iron overload in childhood leukemia by magnetic resonance imaging (MRI). The aim of this study was to determine liver iron content (LIC) by MRI in children with acute lymphoblastic leukemia (ALL) who had completed treatment and to compare those values with serum iron parameters. Materials and Methods: A total of 30 patients between the ages of 7 and 18 who had completed ALL treatment were included in the study. Serum iron parameters (serum iron, serum ferritin [SF], and total iron-binding capacity) and liver function tests were studied. R2 MRI was performed for determining LIC. Results: Normal LIC was detected in 22 (63.4%) of the cases. Seven (23.3%) had mild and 1 (3.3%) had moderate liver iron deposition. In contrast, severe iron overload was not detected in any of the cases. LIC levels were correlated with the numbers of packed red blood cell (pRBC) transfusions (r=0.637, p<0.001), pRBC transfusion volume (r=0.449, p<0.013), SF levels (r=0.561, p=0.001), and transferrin saturation (r=0.353, p=0.044). In addition, a positive correlation was found between the number of pRBC transfusions and SF levels (r=0.595, p<0.001). Conclusion: We showed that the frequency of liver iron deposition was low and clinically less significant after the end of treatment in childhood ALL patients. LIC was demonstrated to be related to SF and transfusion history. These findings support that SF and transfusion history may be used as references for monitoring iron accumulation or identifying cases for further examinations such as MRI.
Objective: There are a limited number of studies evaluating iron overload in childhood leukemia by magnetic resonance imaging (MRI). The aim of this study was to determine liver iron content (LIC) by MRI in children with acute lymphoblastic leukemia (ALL) who had completed treatment and to compare those values with serum iron parameters. Materials and Methods: A total of 30 patients between the ages of 7 and 18 who had completed ALL treatment were included in the study. Serum iron parameters (serum iron, serum ferritin [SF], and total iron-binding capacity) and liver function tests were studied. R2 MRI was performed for determining LIC. Results: Normal LIC was detected in 22 (63.4%) of the cases. Seven (23.3%) had mild and 1 (3.3%) had moderate liver iron deposition. In contrast, severe iron overload was not detected in any of the cases. LIC levels were correlated with the numbers of packed red blood cell (pRBC) transfusions (r=0.637, p<0.001), pRBC transfusion volume (r=0.449, p<0.013), SF levels (r=0.561, p=0.001), and transferrin saturation (r=0.353, p=0.044). In addition, a positive correlation was found between the number of pRBC transfusions and SF levels (r=0.595, p<0.001). Conclusion: We showed that the frequency of liver iron deposition was low and clinically less significant after the end of treatment in childhood ALL patients. LIC was demonstrated to be related to SF and transfusion history. These findings support that SF and transfusion history may be used as references for monitoring iron accumulation or identifying cases for further examinations such as MRI.
Entities:
Keywords:
Acute lymphoblastic leukemia; Iron overload; Complications; Pediatric leukemia
Authors: David Bowen; Dominic Culligan; Simon Jowitt; Stephen Kelsey; Ghulam Mufti; David Oscier; Jane Parker Journal: Br J Haematol Date: 2003-01 Impact factor: 6.998
Authors: Allard W Olthof; Paul E Sijens; Herman G Kreeftenberg; Peter Kappert; Eric J van der Jagt; Matthijs Oudkerk Journal: Eur J Radiol Date: 2008-03-20 Impact factor: 3.528
Authors: V Santini; P E Alessandrino; E Angelucci; G Barosi; A Billio; M Di Maio; C Finelli; F Locatelli; M Marchetti; E Morra; P Musto; G Visani; S Tura Journal: Leuk Res Date: 2010-02-11 Impact factor: 3.156
Authors: Emilio Paolo Alessandrino; Emanuele Angelucci; Mario Cazzola; Matteo Giovanni Della Porta; Paolo Di Bartolomeo; Antonella Gozzini; Luca Malcovati; Pietro Pioltelli; Simona Sica; Alberto Bosi Journal: Am J Hematol Date: 2011-08-02 Impact factor: 10.047
Authors: Jessica L Barrington-Trimis; Myles Cockburn; Catherine Metayer; W James Gauderman; Joseph Wiemels; Roberta McKean-Cowdin Journal: Int J Cancer Date: 2016-11-30 Impact factor: 7.396